Michael W Pennington

Michael W Pennington currently works at Ambiopharm Inc. Michael does research in Peptide Chemistry, Medicinal Chemistry, Organic Chemistry and Biochemistry. One of our current projects is 'Toxins at the interface of ion channel drug development.' This involves toxins which have been isolated from venomous sources which have utility as either tools for research or as potential drugs themselves. We also are very interested in proteolytic enzymes and designing inhibitors and selective substrates for these enzymes.